Hindman Andrew A.

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hindman Andrew A.'s trades of Theravance Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-22 2022-11-18
S Sale
83,898 +45.7%
245.86
US$2,304,705 		83,898 +45.7% 245.86 US$2,304,705